Legal Securities Against Privacy Data for Covid-19 Patients in Indonesia
نویسندگان
چکیده
Disclosure issues priva the patient data cov id-19 has a dilemma, on other hand covid-19 must be protected privacy of her so as not to spread public consumption because it will implications negative for patients towards economic, social , and -Other if medical record is disseminated without perse purpose. Thus, study also describe court decision in which sued peme covid 19 Rinta h area who held press conference post itifnya one sa tu mass media that reported k eadaannya. there are like two sides coin, but hand, information dissemination d ith permission dibutuh right avoid people exposed takes trace contacts virus does spread. That way, protection Covid-19 needs studied answer this dilemma with model . The research method used normative juridical using doctrinal approach. Objective familiarize yourself isa setting clicking Enai Covi -19 Indonesia comparative n egara another. Discussion result showed compassion are, whereas Constitution (Article 28 G paragraph ( 1 )), Article 57 Health Act, some international convention already ratification Indonesia, core had been arranged should case still central or regional governments violate announce very detail about adversely affects patient. Refers protecting EU, UK, US, China, India, Hongkong, Malaysia, Singapura ensures firmly prevent leakage can go general that, maintain patient, tracking integrated via applications guaranteed securities.
منابع مشابه
Assessment of Clinical and Laboratory Data among the Readmitted COVID-19 and Non COVID-19 Patients in Iran
Background and Objective: Hospital readmissions are common and expensive. Identifying the patients who are at high risk of readmission can decrease readmission. Hence, in the present study, the clinical characteristics, biomarker results, and Computed Tomography (CT) criteria of all the readmitted patients were assessed. Materials and Methods: Data of 98 readmitted patients to the Baqiyatallah...
متن کاملThe role of data science in encountering COVID-19 pandemic
The COVID-19 pandemic started in China and quickly spread throughout the world. This pandemic has affected the health of millions of people, the global economy and has challenged the majority of scientists and politicians to find effective medical treatments and intelligent policies to reduce the side effects of this pandemic as soon as possible. Technological advancements have enabled us to co...
متن کاملTherapeutic potential of Paclitaxel against COVID-19
The coronavirus disease-2019(COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), is a single-stranded RNA virus and belongs to the large Coronaviridae family. Paclitaxel, an antineoplastic drug extracted from the Tax...
متن کاملCOVID-19 and its Outcomes in Multiple Sclerosis Patients
Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs will reduce the patient’s immune system resistance against COVID19. Objectives: This study aimed to evaluate the epidemiology of COVID19 and its ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Veteran Law Review
سال: 2021
ISSN: ['2655-1594', '2655-1608']
DOI: https://doi.org/10.35586/velrev.v4i1.2618